Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ · CTNM
Fundamentals
Market cap
$550.70M
Price / Earnings ratio
-9.4x
Price / Sales ratio
N/A
Price / Book ratio
2.2x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


